A 6-Month Study to Evaluate the Safety & Potential Efficacy of Trappsol Cyclo in Patients With Early Alzheimer's Disease
Clinical trial NCT05607615 · UNKNOWN
Trial details
- NCT number
- NCT05607615
- Sponsor
- Cyclo Therapeutics, Inc.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-23
- Primary completion
- 2024-03-31
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.